Beam Therapeutics Inc. (BEAM) Net income 2019–2025
Beam Therapeutics Inc. (BEAM) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$80.0MFY2025 · since FY2019: -$78.3M → -$80.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$80.0M | +78.8% |
| FY2024 | -$376.7M | -184.3% |
| FY2023 | -$132.5M | +54.2% |
| FY2022 | -$289.1M | +22.0% |
| FY2021 | -$370.6M | -90.5% |
| FY2020 | -$194.6M | -148.4% |
| FY2019 | -$78.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BEAM financial trends
BEAM RevenueBEAM Net marginBEAM Gross profitBEAM Gross marginBEAM Operating incomeBEAM Operating marginBEAM Operating cash flowBEAM Free cash flowBEAM Capital expendituresBEAM Return on equityBEAM Stock buybacksBEAM Dividends paidBEAM Total assetsBEAM Total liabilitiesBEAM Shareholders’ equityBEAM overview →